1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Rajagopal, P.
Klevit, R.E.
Shi, L.
Baker, D.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Elife
2050-084X
4
10.7554/eLife.07304
25962097
A conserved histidine modulates HSPB5 structure to trigger chaperone activity in response to stress-related acidosis.
2015
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
385
1481
1497
10.1016/j.jmb.2008.10.097
19041879
alphaB-crystallin: a hybrid solid-state/solution-state NMR investigation reveals structural aspects of the heterogeneous oligomer.
2009
US
Nat.Struct.Mol.Biol.
1545-9993
17
1037
1042
10.1038/nsmb.1891
20802487
Solid-state NMR and SAXS studies provide a structural basis for the activation of alphaB-crystallin oligomers.
2010
US
Proc.Natl.Acad.Sci.USA
PNASA6
0040
0027-8424
108
6409
6414
10.1073/pnas.1014656108
21464278
N-terminal domain of alphaB-crystallin provides a conformational switch for multimerization and structural heterogeneity.
2011
10.2210/pdb2n0k/pdb
pdb_00002n0k
10200.497
Alpha-crystallin B chain
unp residues 64-152
N146D
2
man
polymer
Alpha(B)-crystallin, Heat shock protein beta-5, HspB5, Renal carcinoma antigen NY-REN-27, Rosenthal fiber component
no
no
GLSEMRLEKDRFSVNLDVKHFSPEELKVKVLGDVIEVHGKHEERQDEHGFISREFHRKYRIPADVDPLTITSSLSSDGVL
TVDGPRKQV
GLSEMRLEKDRFSVNLDVKHFSPEELKVKVLGDVIEVHGKHEERQDEHGFISREFHRKYRIPADVDPLTITSSLSSDGVL
TVDGPRKQV
A,B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
sample
CRYA2, CRYAB
9606
Homo sapiens
469008
Escherichia coli
BL21 (DE3)
pET24a
database_2
pdbx_database_status
pdbx_nmr_software
pdbx_nmr_spectrometer
struct_ref_seq_dif
struct_sheet
repository
Initial release
Database references
Database references
Data collection
Database references
Derived calculations
Other
1
0
2015-06-03
1
1
2015-07-22
1
2
2017-02-15
1
3
2023-06-14
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.status_code_nmr_data
_pdbx_nmr_software.name
_pdbx_nmr_spectrometer.model
_struct_ref_seq_dif.details
_struct_sheet.number_strands
NMR distance, dihedral, and residual dipolar coupling constraints.
BMRB
Y
RCSB
2015-03-09
REL
REL
REL
REL
838
310
188
85
255
72
72
Solution structure was determined with NOEs and RDCs.
structures with the lowest energy
100
9
2D 1H-15N HSQC
2D 1H-15N HSQC
2D 1H-15N HSQC
3D 1H-15N NOESY
2D 1H-13C HSQC aliphatic
2D 1H-13C HSQC aromatic
3D HNCACB
3D HBHA(CO)NH
3D HNCO
3D HNCA
3D HN(CO)CA
3D HN(COCA)CB
3D HCCH-TOCSY
3D H(CCO)NH
3D C(CO)NH
0.2-1.0
mM
[U-100% 13C; U-100% 15N]
50
mM
100
mM
.1
mM
1
mM
0.2-1.0
mM
[U-100% 13C; U-100% 15N; U-80% 2H]
50
mM
100
mM
.1
mM
1
mM
0.2-1.0
mM
[U-100% 13C; U-100% 15N; U-80% 2H]
50
mM
100
mM
.1
mM
1
mM
14
mg/mL
1.0
mM
[U-100% 13C; U-100% 15N]
50
mM
100
mM
.1
mM
1
mM
1.0
mM
[U-100% 13C; U-100% 15N; 50% 2H]
50
mM
100
mM
.1
mM
1
mM
100
7.5
ambient
295
K
100
6.5
ambient
295
K
simulated annealing
1
closest to the average
0.6 mM [U-100% 13C; U-100% 15N] HSPB5-ACD, 50 mM sodium phosphate, 100 mM sodium chloride, .1 mM EDTA, 1 mM PMSF, 90% H2O/10% D2O
90% H2O/10% D2O
0.6 mM [U-100% 13C; U-100% 15N; U-80% 2H] HSPB5-ACD, 50 mM sodium phosphate, 100 mM sodium chloride, .1 mM EDTA, 1 mM PMSF, 90% H2O/10% D2O
90% H2O/10% D2O
0.6 mM [U-100% 13C; U-100% 15N; U-80% 2H] HSPB5-ACD, 50 mM sodium phosphate, 100 mM sodium chloride, .1 mM EDTA, 1 mM PMSF, 14 mg/mL Pf1 phage, 90% H2O/10% D2O
90% H2O/10% D2O
1.0 mM [U-100% 13C; U-100% 15N] HSPB5-ACD, 50 mM sodium phosphate, 100 mM sodium chloride, .1 mM EDTA, 1 mM PMSF, 100% D2O
100% D2O
1.0 mM [U-100% 13C; U-100% 15N; 50% 2H] HSPB5-ACD, 50 mM sodium phosphate, 100 mM sodium chloride, .1 mM EDTA, 1 mM PMSF, 90% H2O/10% D2O
90% H2O/10% D2O
Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
data analysis
NMRPipe
Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
processing
NMRPipe
Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
peak picking
NMRPipe
Johnson, One Moon Scientific
data analysis
NMRView
Johnson, One Moon Scientific
chemical shift assignment
NMRView
Johnson, One Moon Scientific
peak picking
NMRView
Zimmerman, Moseley, Kulikowski and Montelione
chemical shift assignment
AutoAssign
Zimmerman, Moseley, Kulikowski and Montelione
peak picking
AutoAssign
Shen, Vernon, Baker and Bax
structure solution
CS-ROSETTA
Shen, Vernon, Baker and Bax
chemical shift assignment
CS-ROSETTA
Shen, Vernon, Baker and Bax
peak picking
CS-ROSETTA
(RosettaOligomer)-Sgourakis, Lange, DiMaio, Andre, Fitzkee, Rossi, Montelione, Bax, Baker
structure solution
RosettaOligomer
(RosettaOligomer)-Sgourakis, Lange, DiMaio, Andre, Fitzkee, Rossi, Montelione, Bax, Baker
chemical shift assignment
RosettaOligomer
(RosettaOligomer)-Sgourakis, Lange, DiMaio, Andre, Fitzkee, Rossi, Montelione, Bax, Baker
peak picking
RosettaOligomer
Cornilescu, Delaglio and Bax
refinement
TALOS
Cornilescu, Delaglio and Bax
chemical shift assignment
TALOS
Cornilescu, Delaglio and Bax
peak picking
TALOS
(GUARDD)-Kleckner, Foster
data analysis
GUARDD
(GUARDD)-Kleckner, Foster
chemical shift assignment
GUARDD
(GUARDD)-Kleckner, Foster
peak picking
GUARDD
refinement
RosettaOligomer
800
Bruker
AVANCE
Bruker Avance
600
Bruker
AVANCE
Bruker Avance
500
Bruker
AVANCE
Bruker Avance
900
Bruker
AVANCE
Bruker Avance
GLY
64
n
1
GLY
64
A
LEU
65
n
2
LEU
65
A
SER
66
n
3
SER
66
A
GLU
67
n
4
GLU
67
A
MET
68
n
5
MET
68
A
ARG
69
n
6
ARG
69
A
LEU
70
n
7
LEU
70
A
GLU
71
n
8
GLU
71
A
LYS
72
n
9
LYS
72
A
ASP
73
n
10
ASP
73
A
ARG
74
n
11
ARG
74
A
PHE
75
n
12
PHE
75
A
SER
76
n
13
SER
76
A
VAL
77
n
14
VAL
77
A
ASN
78
n
15
ASN
78
A
LEU
79
n
16
LEU
79
A
ASP
80
n
17
ASP
80
A
VAL
81
n
18
VAL
81
A
LYS
82
n
19
LYS
82
A
HIS
83
n
20
HIS
83
A
PHE
84
n
21
PHE
84
A
SER
85
n
22
SER
85
A
PRO
86
n
23
PRO
86
A
GLU
87
n
24
GLU
87
A
GLU
88
n
25
GLU
88
A
LEU
89
n
26
LEU
89
A
LYS
90
n
27
LYS
90
A
VAL
91
n
28
VAL
91
A
LYS
92
n
29
LYS
92
A
VAL
93
n
30
VAL
93
A
LEU
94
n
31
LEU
94
A
GLY
95
n
32
GLY
95
A
ASP
96
n
33
ASP
96
A
VAL
97
n
34
VAL
97
A
ILE
98
n
35
ILE
98
A
GLU
99
n
36
GLU
99
A
VAL
100
n
37
VAL
100
A
HIS
101
n
38
HIS
101
A
GLY
102
n
39
GLY
102
A
LYS
103
n
40
LYS
103
A
HIS
104
n
41
HIS
104
A
GLU
105
n
42
GLU
105
A
GLU
106
n
43
GLU
106
A
ARG
107
n
44
ARG
107
A
GLN
108
n
45
GLN
108
A
ASP
109
n
46
ASP
109
A
GLU
110
n
47
GLU
110
A
HIS
111
n
48
HIS
111
A
GLY
112
n
49
GLY
112
A
PHE
113
n
50
PHE
113
A
ILE
114
n
51
ILE
114
A
SER
115
n
52
SER
115
A
ARG
116
n
53
ARG
116
A
GLU
117
n
54
GLU
117
A
PHE
118
n
55
PHE
118
A
HIS
119
n
56
HIS
119
A
ARG
120
n
57
ARG
120
A
LYS
121
n
58
LYS
121
A
TYR
122
n
59
TYR
122
A
ARG
123
n
60
ARG
123
A
ILE
124
n
61
ILE
124
A
PRO
125
n
62
PRO
125
A
ALA
126
n
63
ALA
126
A
ASP
127
n
64
ASP
127
A
VAL
128
n
65
VAL
128
A
ASP
129
n
66
ASP
129
A
PRO
130
n
67
PRO
130
A
LEU
131
n
68
LEU
131
A
THR
132
n
69
THR
132
A
ILE
133
n
70
ILE
133
A
THR
134
n
71
THR
134
A
SER
135
n
72
SER
135
A
SER
136
n
73
SER
136
A
LEU
137
n
74
LEU
137
A
SER
138
n
75
SER
138
A
SER
139
n
76
SER
139
A
ASP
140
n
77
ASP
140
A
GLY
141
n
78
GLY
141
A
VAL
142
n
79
VAL
142
A
LEU
143
n
80
LEU
143
A
THR
144
n
81
THR
144
A
VAL
145
n
82
VAL
145
A
ASP
146
n
83
ASP
146
A
GLY
147
n
84
GLY
147
A
PRO
148
n
85
PRO
148
A
ARG
149
n
86
ARG
149
A
LYS
150
n
87
LYS
150
A
GLN
151
n
88
GLN
151
A
VAL
152
n
89
VAL
152
A
GLY
64
n
1
GLY
64
B
LEU
65
n
2
LEU
65
B
SER
66
n
3
SER
66
B
GLU
67
n
4
GLU
67
B
MET
68
n
5
MET
68
B
ARG
69
n
6
ARG
69
B
LEU
70
n
7
LEU
70
B
GLU
71
n
8
GLU
71
B
LYS
72
n
9
LYS
72
B
ASP
73
n
10
ASP
73
B
ARG
74
n
11
ARG
74
B
PHE
75
n
12
PHE
75
B
SER
76
n
13
SER
76
B
VAL
77
n
14
VAL
77
B
ASN
78
n
15
ASN
78
B
LEU
79
n
16
LEU
79
B
ASP
80
n
17
ASP
80
B
VAL
81
n
18
VAL
81
B
LYS
82
n
19
LYS
82
B
HIS
83
n
20
HIS
83
B
PHE
84
n
21
PHE
84
B
SER
85
n
22
SER
85
B
PRO
86
n
23
PRO
86
B
GLU
87
n
24
GLU
87
B
GLU
88
n
25
GLU
88
B
LEU
89
n
26
LEU
89
B
LYS
90
n
27
LYS
90
B
VAL
91
n
28
VAL
91
B
LYS
92
n
29
LYS
92
B
VAL
93
n
30
VAL
93
B
LEU
94
n
31
LEU
94
B
GLY
95
n
32
GLY
95
B
ASP
96
n
33
ASP
96
B
VAL
97
n
34
VAL
97
B
ILE
98
n
35
ILE
98
B
GLU
99
n
36
GLU
99
B
VAL
100
n
37
VAL
100
B
HIS
101
n
38
HIS
101
B
GLY
102
n
39
GLY
102
B
LYS
103
n
40
LYS
103
B
HIS
104
n
41
HIS
104
B
GLU
105
n
42
GLU
105
B
GLU
106
n
43
GLU
106
B
ARG
107
n
44
ARG
107
B
GLN
108
n
45
GLN
108
B
ASP
109
n
46
ASP
109
B
GLU
110
n
47
GLU
110
B
HIS
111
n
48
HIS
111
B
GLY
112
n
49
GLY
112
B
PHE
113
n
50
PHE
113
B
ILE
114
n
51
ILE
114
B
SER
115
n
52
SER
115
B
ARG
116
n
53
ARG
116
B
GLU
117
n
54
GLU
117
B
PHE
118
n
55
PHE
118
B
HIS
119
n
56
HIS
119
B
ARG
120
n
57
ARG
120
B
LYS
121
n
58
LYS
121
B
TYR
122
n
59
TYR
122
B
ARG
123
n
60
ARG
123
B
ILE
124
n
61
ILE
124
B
PRO
125
n
62
PRO
125
B
ALA
126
n
63
ALA
126
B
ASP
127
n
64
ASP
127
B
VAL
128
n
65
VAL
128
B
ASP
129
n
66
ASP
129
B
PRO
130
n
67
PRO
130
B
LEU
131
n
68
LEU
131
B
THR
132
n
69
THR
132
B
ILE
133
n
70
ILE
133
B
THR
134
n
71
THR
134
B
SER
135
n
72
SER
135
B
SER
136
n
73
SER
136
B
LEU
137
n
74
LEU
137
B
SER
138
n
75
SER
138
B
SER
139
n
76
SER
139
B
ASP
140
n
77
ASP
140
B
GLY
141
n
78
GLY
141
B
VAL
142
n
79
VAL
142
B
LEU
143
n
80
LEU
143
B
THR
144
n
81
THR
144
B
VAL
145
n
82
VAL
145
B
ASP
146
n
83
ASP
146
B
GLY
147
n
84
GLY
147
B
PRO
148
n
85
PRO
148
B
ARG
149
n
86
ARG
149
B
LYS
150
n
87
LYS
150
B
GLN
151
n
88
GLN
151
B
VAL
152
n
89
VAL
152
B
author_defined_assembly
2
dimeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
B
B
HD1
HH11
HIS
ARG
104
107
1.21
1
A
A
HD1
HH11
HIS
ARG
104
107
1.21
2
B
B
HD1
HH11
HIS
ARG
104
107
1.25
2
A
A
HD1
HH11
HIS
ARG
104
107
1.25
3
B
B
HG
H
SER
ASP
138
140
1.32
3
A
A
HG
H
SER
ASP
138
140
1.33
3
A
A
HD1
HE
HIS
ARG
104
116
1.34
3
B
B
HD1
HE
HIS
ARG
104
116
1.34
4
A
A
HG
H
SER
ASP
138
140
1.33
5
A
A
HG
H
SER
VAL
138
142
1.32
6
B
B
HG
H
SER
VAL
138
142
1.35
9
A
B
H
O
LYS
PHE
121
113
1.60
1
A
SER
66
-141.58
27.22
1
A
GLU
71
-68.99
-179.25
1
A
LYS
72
-29.53
-59.97
1
A
ASP
73
-146.45
46.41
1
A
HIS
101
-60.78
75.66
1
A
ASP
109
-154.61
-147.75
1
B
SER
66
-141.61
27.25
1
B
GLU
71
-69.06
-179.37
1
B
LYS
72
-29.29
-60.02
1
B
ASP
73
-146.53
46.49
1
B
HIS
101
-60.67
75.53
1
B
ASP
109
-154.50
-147.61
2
A
MET
68
-37.57
119.52
2
A
LYS
72
-13.40
-70.44
2
A
ASP
73
-143.05
44.42
2
A
ARG
74
-170.82
135.76
2
A
HIS
83
72.21
34.26
2
A
LEU
94
-105.94
68.64
2
A
LYS
103
-170.58
120.18
2
A
ASP
109
-133.81
-157.87
2
A
SER
136
-171.67
146.95
2
B
MET
68
-37.57
119.48
2
B
LYS
72
-13.60
-70.43
2
B
ASP
73
-142.83
44.40
2
B
ARG
74
-170.88
135.59
2
B
HIS
83
72.25
34.24
2
B
LEU
94
-105.97
68.63
2
B
LYS
103
-170.53
120.19
2
B
ASP
109
-133.85
-157.89
2
B
SER
136
-171.65
146.98
3
A
GLU
71
-114.56
-149.85
3
A
ASP
73
-151.89
33.79
3
A
PHE
75
-163.88
119.69
3
A
VAL
81
-147.55
34.30
3
A
HIS
101
-102.83
64.58
3
A
ASP
109
-116.54
-147.73
3
A
ARG
116
-108.72
75.77
3
A
LYS
121
-67.12
76.87
3
A
ARG
149
-59.40
171.64
3
B
GLU
71
-114.70
-149.79
3
B
ASP
73
-151.89
33.76
3
B
PHE
75
-163.79
119.82
3
B
VAL
81
-147.55
34.17
3
B
HIS
101
-102.86
64.60
3
B
ASP
109
-116.51
-147.77
3
B
ARG
116
-108.64
75.72
3
B
LYS
121
-67.26
76.81
3
B
ARG
149
-59.47
171.61
4
A
LYS
72
-27.26
-61.66
4
A
ASP
73
-144.55
44.59
4
A
ARG
74
-178.57
144.27
4
A
GLU
105
-66.43
-175.52
4
A
GLU
106
-25.64
116.44
4
A
GLN
108
-45.48
109.44
4
A
ASP
109
-164.15
-136.73
4
A
HIS
111
-111.43
79.80
4
A
LYS
121
-68.59
78.93
4
A
PRO
125
-46.24
153.32
4
B
LYS
72
-27.25
-61.60
4
B
ASP
73
-144.56
44.55
4
B
ARG
74
-178.58
144.25
4
B
GLU
105
-66.59
-175.57
4
B
GLU
106
-25.56
116.42
4
B
GLN
108
-45.30
109.42
4
B
ASP
109
-164.15
-136.77
4
B
HIS
111
-111.26
79.74
4
B
LYS
121
-68.59
78.95
4
B
PRO
125
-46.37
153.35
5
A
LYS
72
-27.54
-58.99
5
A
ASP
73
-152.82
56.68
5
A
ARG
74
-160.22
106.81
5
A
VAL
81
-144.02
31.35
5
A
LYS
82
-89.37
45.28
5
A
HIS
83
-141.32
-5.20
5
A
VAL
100
-68.54
87.53
5
A
ARG
149
-48.95
151.73
5
B
LYS
72
-27.54
-58.89
5
B
ASP
73
-152.87
56.73
5
B
ARG
74
-160.30
106.80
5
B
VAL
81
-144.09
31.40
5
B
LYS
82
-89.23
45.02
5
B
HIS
83
-141.20
-5.15
5
B
VAL
100
-68.57
87.63
5
B
ARG
149
-48.88
151.76
6
A
GLU
71
-67.13
-175.61
6
A
ASP
73
-149.93
36.38
6
A
ASP
109
-116.95
-169.98
6
A
ARG
149
-76.55
-169.20
6
B
GLU
71
-67.11
-175.60
6
B
ASP
73
-149.76
36.34
6
B
ARG
149
-76.42
-169.21
7
A
LYS
72
-28.19
-59.52
7
A
LYS
82
-27.47
-59.19
7
A
ASP
109
-133.59
-158.17
7
A
HIS
119
-162.53
60.95
7
A
LYS
150
-36.93
110.23
7
B
LYS
72
-28.19
-59.64
7
B
LYS
82
-27.54
-59.03
7
B
ASP
109
-133.40
-158.20
7
B
HIS
119
-162.42
61.01
7
B
LYS
150
-36.88
110.27
8
A
GLU
71
-68.38
-176.30
8
A
LYS
72
-27.15
-60.17
8
A
ASP
73
-142.54
26.78
8
A
HIS
101
-103.05
64.75
8
A
ASP
109
-160.36
-149.79
8
A
HIS
119
-163.60
62.45
8
B
GLU
71
-68.11
-176.25
8
B
LYS
72
-27.29
-60.24
8
B
ASP
73
-142.34
26.74
8
B
HIS
101
-102.98
64.72
8
B
ASP
109
-160.32
-149.70
8
B
HIS
119
-163.64
62.34
9
A
LYS
72
-29.11
-57.35
9
A
PHE
75
-172.50
84.58
9
A
ILE
98
-119.02
68.51
9
A
GLU
99
-54.95
100.95
9
A
ARG
120
-68.15
93.81
9
A
LYS
121
-68.09
76.60
9
A
TYR
122
-59.49
106.86
9
B
LYS
72
-29.11
-57.36
9
B
PHE
75
-172.51
84.58
9
B
ILE
98
-119.03
68.47
9
B
GLU
99
-54.92
100.88
9
B
ARG
120
-68.14
93.92
9
B
LYS
121
-68.04
76.53
9
B
TYR
122
-59.58
106.86
closest to the average, model1
Chemical shift assignments and structure of the alpha-crystallin domain from human, HSPB5
1
N
N
1
N
N
A
ASP
129
A
ASP
66
HELX_P
A
ILE
133
A
ILE
70
5
1
5
B
ASP
129
B
ASP
66
HELX_P
B
ILE
133
B
ILE
70
5
2
5
METAL BINDING PROTEIN
crystallin, human, ACD, Protein, METAL BINDING PROTEIN
A
GLY
112
A
GLY
49
5
A
PHE
113
A
PHE
50
9.52
B
GLY
112
B
GLY
49
5
B
PHE
113
B
PHE
50
9.62
CRYAB_HUMAN
UNP
1
64
P02511
GLSEMRLEKDRFSVNLDVKHFSPEELKVKVLGDVIEVHGKHEERQDEHGFISREFHRKYRIPADVDPLTITSSLSSDGVL
TVNGPRKQV
64
152
2N0K
64
152
P02511
A
1
1
89
64
152
2N0K
64
152
P02511
B
1
1
89
1
ASN
engineered mutation
ASP
146
2N0K
A
P02511
UNP
146
83
2
ASN
engineered mutation
ASP
146
2N0K
B
P02511
UNP
146
83
6
6
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
PHE
75
A
PHE
12
A
LEU
79
A
LEU
16
A
VAL
142
A
VAL
79
A
ASP
146
A
ASP
83
A
THR
134
A
THR
71
A
LEU
137
A
LEU
74
A
LEU
89
A
LEU
26
A
LEU
94
A
LEU
31
A
VAL
97
A
VAL
34
A
HIS
104
A
HIS
41
A
GLY
112
A
GLY
49
A
ARG
123
A
ARG
60
B
GLY
112
B
GLY
49
B
ARG
123
B
ARG
60
B
VAL
97
B
VAL
34
B
HIS
104
B
HIS
41
B
LEU
89
B
LEU
26
B
LEU
94
B
LEU
31
B
PHE
75
B
PHE
12
B
LEU
79
B
LEU
16
B
VAL
142
B
VAL
79
B
ASP
146
B
ASP
83
B
THR
134
B
THR
71
B
LEU
137
B
LEU
74